FBRX

Forte Biosciences, Inc. [FBRX] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

FBRX Stock Summary

Top 10 Correlated ETFs

FBRX

Top 10 Correlated Stocks

FBRX

In the News

FBRX Financial details

Company Rating
-
Market Cap
26.32M
Income
-31.37M
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
9
Optionable
No
Shortable
Yes
Earnings
13 May 2024
P/E
-1.06
Forward P/E
-
PEG
-0.24
P/S
-
P/B
0.8
P/C
-
P/FCF
-1.36
Quick Ratio
6.18
Current Ratio
6.3
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-1.16
EPS next Y
-
EPS next Q
-
EPS this Y
25%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-38.46%
-
-
-
-
SMA20
-29.27%
SMA50
-51.88%
SMA100
64.97%
Inst Own
-
Inst Trans
-
ROA
-63%
ROE
-89%
ROC
-0.77%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.38-1.15
52W High
-
52W Low
-
RSI
36.52
Rel Volume
0.35
Avg Volume
34.26K
Volume
12.02K
Perf Week
-1.17%
Perf Month
-47.14%
Perf Quarter
42.04%
Perf Half Y
32.61%
-
-
-
-
Beta
1.655
-
-
Volatility
0.55%, 2.38%
Prev Close
2.62%
Price
10.98
Change
9.69%

Something similar

Top by Market Cap
DHR-PB
GOOGL
VOO
LLY.DE
EMBASSY.NS
Top Correlated ETFs
TSL
TSLL
ITB
IDX
NAIL
Top Correlated Stocks
DHI
DLX
RETO
0I6K.L
EFSI
Similar Market Cap
H4ZD.DE
DECD.F
ILDR
CLDS
POS.L

Company Profile

Healthcare Biotechnology
  • Volume Average 34.26K
  • Market Capitalization 26.32M
  • Employee 9
  • CEO Dr. Paul A. Wagner Ph.D.
  • Headquarters Dallas,TX,US
  • IPO Date 2017-04-13
  • Website https://www.fortebiorx.com

Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.